Cargando…

A novel mutation affecting the arginine‐137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin‐2

Mutations in the vasopressin V2 receptor gene AVPR2 may cause X‐linked nephrogenic diabetes insipidus by defective apical insertion of aquaporin‐2 in the renal collecting duct principal cell. Substitution mutations with exchange of arginine at codon 137 can cause nephrogenic syndrome of inappropriat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinrichs, Gitte R., Hansen, Louise H., Nielsen, Maria R., Fagerberg, Christina, Dieperink, Hans, Rittig, Søren, Jensen, Boye L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848722/
https://www.ncbi.nlm.nih.gov/pubmed/27117808
http://dx.doi.org/10.14814/phy2.12764
_version_ 1782429405065248768
author Hinrichs, Gitte R.
Hansen, Louise H.
Nielsen, Maria R.
Fagerberg, Christina
Dieperink, Hans
Rittig, Søren
Jensen, Boye L.
author_facet Hinrichs, Gitte R.
Hansen, Louise H.
Nielsen, Maria R.
Fagerberg, Christina
Dieperink, Hans
Rittig, Søren
Jensen, Boye L.
author_sort Hinrichs, Gitte R.
collection PubMed
description Mutations in the vasopressin V2 receptor gene AVPR2 may cause X‐linked nephrogenic diabetes insipidus by defective apical insertion of aquaporin‐2 in the renal collecting duct principal cell. Substitution mutations with exchange of arginine at codon 137 can cause nephrogenic syndrome of inappropriate antidiuresis or congenital X‐linked nephrogenic diabetes insipidus. We present a novel mutation in codon 137 within AVPR2 with substitution of glycine for arginine in male dizygotic twins. Nephrogenic diabetes insipidus was demonstrated by water deprivation test and resistance to vasopressin administration. While a similar urine exosome release rate was shown between probands and controls by western blotting for the marker ALIX, there was a selective decrease in exosome aquaporin‐2 versus aquaporin‐1 protein in probands compared to controls.
format Online
Article
Text
id pubmed-4848722
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-48487222016-05-04 A novel mutation affecting the arginine‐137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin‐2 Hinrichs, Gitte R. Hansen, Louise H. Nielsen, Maria R. Fagerberg, Christina Dieperink, Hans Rittig, Søren Jensen, Boye L. Physiol Rep Case Reports Mutations in the vasopressin V2 receptor gene AVPR2 may cause X‐linked nephrogenic diabetes insipidus by defective apical insertion of aquaporin‐2 in the renal collecting duct principal cell. Substitution mutations with exchange of arginine at codon 137 can cause nephrogenic syndrome of inappropriate antidiuresis or congenital X‐linked nephrogenic diabetes insipidus. We present a novel mutation in codon 137 within AVPR2 with substitution of glycine for arginine in male dizygotic twins. Nephrogenic diabetes insipidus was demonstrated by water deprivation test and resistance to vasopressin administration. While a similar urine exosome release rate was shown between probands and controls by western blotting for the marker ALIX, there was a selective decrease in exosome aquaporin‐2 versus aquaporin‐1 protein in probands compared to controls. John Wiley and Sons Inc. 2016-04-25 /pmc/articles/PMC4848722/ /pubmed/27117808 http://dx.doi.org/10.14814/phy2.12764 Text en © 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Hinrichs, Gitte R.
Hansen, Louise H.
Nielsen, Maria R.
Fagerberg, Christina
Dieperink, Hans
Rittig, Søren
Jensen, Boye L.
A novel mutation affecting the arginine‐137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin‐2
title A novel mutation affecting the arginine‐137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin‐2
title_full A novel mutation affecting the arginine‐137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin‐2
title_fullStr A novel mutation affecting the arginine‐137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin‐2
title_full_unstemmed A novel mutation affecting the arginine‐137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin‐2
title_short A novel mutation affecting the arginine‐137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin‐2
title_sort novel mutation affecting the arginine‐137 residue of avpr2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin‐2
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848722/
https://www.ncbi.nlm.nih.gov/pubmed/27117808
http://dx.doi.org/10.14814/phy2.12764
work_keys_str_mv AT hinrichsgitter anovelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2
AT hansenlouiseh anovelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2
AT nielsenmariar anovelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2
AT fagerbergchristina anovelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2
AT dieperinkhans anovelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2
AT rittigsøren anovelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2
AT jensenboyel anovelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2
AT hinrichsgitter novelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2
AT hansenlouiseh novelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2
AT nielsenmariar novelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2
AT fagerbergchristina novelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2
AT dieperinkhans novelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2
AT rittigsøren novelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2
AT jensenboyel novelmutationaffectingthearginine137residueofavpr2indizygoustwinsleadstonephrogenicdiabetesinsipidusandattenuatedurineexosomeaquaporin2